The Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study

The Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study

Background: Existing treatments are inadequate for patients at high risk of coronary heart disease caused by elevated levels of plasma low-density lipoprotein cholesterol (LDL-C). Bambuterol is a prodrug of β2-agonist commonly used for the treatment of asthma and chronic obstructive pulmonary diseas...

Full description

Bibliographic Details
Main Authors: Yanrui Ye, Hang Xu, Lei Quan, Long Zhu, Jing Zeng, Ting Zhou, ChengJuan Zou, Qing Cheng, Shujie Bu, Wen Tan
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:EBioMedicine
Subjects:
β2-Agonist
R-bambuterol
Cholesterol
LDL-C
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396415000493

Similar Items

Similar Items